menu
    • menu

    Company profile for Suzhou Connect Biopharmaceuticals

    NEW Drugs in Dev: 1
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Connect Biopharmaceuticals is a clinical-stage company focused on discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Our aim is to improve the liv...
    Connect Biopharmaceuticals is a clinical-stage company focused on discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Our aim is to improve the lives of patients in China and around the world by creating novel medicines with better efficacy and fewer side effects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Suzhou Connect BiopharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    Science and Technology Park, East R&D Building , 3rd Floor , ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.connectbiopharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Connect reduces China workforce, mulls strategy for potential Dupixent rival
    Connect reduces China workforce, mulls strategy for potential Dupixent rival

    06 Sep 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/connect-reduces-china-workforce-mulls-strategy-lead-asthma-drug

    FIERCE BIOTECH
    06 Sep 2024
    Share Share
    Connect Biopharma Enhances its Intellectual Property Estate for CBP-307
    Connect Biopharma Enhances its Intellectual Property Estate for CBP-307

    25 Feb 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/connect-biopharma-enhances-its-intellectual-property-estate-for-cbp-307-a-targeted-therapy-with-potential-in-multiple-autoimmune-diseases-with-patent-issuances-in-the-united-states-eu-japan-and-australia-301010279.html

    PR NEWSWIRE
    25 Feb 2020
    Share Share
    Connect Biopharma Reports Positive Topline Data D
    Connect Biopharma Reports Positive Topline Data D

    08 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html

    PR NEWSWIRE
    08 Jan 2020
    Share Share
    Connect Biopharma Reports Positive Topline Data D
    Connect Biopharma Reports Positive Topline Data D

    07 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html

    PR NEWSWIRE
    07 Jan 2020
    Share Share
    Connect Biopharma Reports Positive Topline Data D
    Connect Biopharma Reports Positive Topline Data D

    07 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html

    PR NEWSWIRE
    07 Jan 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search